Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Moodys
AstraZeneca
Express Scripts
Merck

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 215158


Email this page to a colleague

« Back to Dashboard

NDA 215158 describes CHLORZOXAZONE, which is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Glenmark Pharms Ltd, I3 Pharms, Mayne Pharma, Mikart, Novitium Pharma, Ohm Labs, Par Pharm, Par Pharm Inc, Pioneer Pharms, Rising, Senores Pharms, Sun Pharm Industries, Teva Pharms Usa Inc, and Watson Labs, and is included in twenty-seven NDAs. It is available from twenty-three suppliers. Additional details are available on the CHLORZOXAZONE profile page.

The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 215158
Tradename:CHLORZOXAZONE
Applicant:Senores Pharms
Ingredient:chlorzoxazone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 215158
Medical Subject Heading (MeSH) Categories for 215158
Suppliers and Packaging for NDA: 215158
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORZOXAZONE chlorzoxazone TABLET;ORAL 215158 ANDA Cintex Services, LLC 24470-923 24470-923-10 100 TABLET in 1 BOTTLE (24470-923-10)
CHLORZOXAZONE chlorzoxazone TABLET;ORAL 215158 ANDA Cintex Services, LLC 24470-923 24470-923-60 60 TABLET in 1 BOTTLE (24470-923-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Jul 29, 2021TE:AARLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Harvard Business School
Medtronic
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.